Tianjin Zhongxin Pharmaceutical Group Corp Ltd

600329 • SHG

¥34.36+¥0.32 (0.94%)

Estimate

P/E

EPS

1.11

Beta

0.519

Growth

Revenue, YoY

-21.4%

Net income, YoY

-85.78%

FCF, YoY

241.69%

Forecast

P/E (FWD)

22.3

EPS (FWD)

1.54

About the company

Ticker

600329

ISIN

CNE000001808

Country

China

Sector (GICS)

Healthcare

Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited engages in the research, development, processing, manufacturing, and sale of traditional Chinese medicine in China. It provides pharmaceutical products for cardiovascular and cerebrovascular, skin wound repair, health preservation, respiratory, digestion, rheumatism and osteodynia, urological, gynecological and pediatric, ophthalmological, tumor, chronic, and other diseases, as well as tonic drugs. The company was formerly known as Tianjin Zhong Xin Pharmaceutical Group Corporation Limited and changed its name to Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited in May 2022. The company was founded in 1915 and is based in Tianjin, the People's Republic of China.

Frequently asked questions

What sector does Tianjin Zhongxin Pharmaceutical Group Corp Ltd (600329) operate in?

Tianjin Zhongxin Pharmaceutical Group Corp Ltd belongs to the Healthcare sector and operates in the Drug Manufacturers - Specialty & Generic industry.

What is Tianjin Zhongxin Pharmaceutical Group Corp Ltd (600329) current stock price?

As of the latest data, Tianjin Zhongxin Pharmaceutical Group Corp Ltd stock price is CN¥34.36, with a previous close of CN¥34.04. Tianjin Zhongxin Pharmaceutical Group Corp Ltd gained CN¥0.32 in the last trading session, representing a 0.94% increase.

What is Tianjin Zhongxin Pharmaceutical Group Corp Ltd (600329) current market capitalization?

Tianjin Zhongxin Pharmaceutical Group Corp Ltd market cap is approximately 19.59 billion.

What is Tianjin Zhongxin Pharmaceutical Group Corp Ltd (600329) Earnings Per Share (EPS)?

The trailing EPS is CN¥1.11, and the forward EPS is CN¥1.54.

What is Tianjin Zhongxin Pharmaceutical Group Corp Ltd (600329) Price-to-Earnings (P/E) ratio?

Tianjin Zhongxin Pharmaceutical Group Corp Ltd current P/E ratio is 30.95, with a forward P/E of 22.31.

Does Tianjin Zhongxin Pharmaceutical Group Corp Ltd (600329) pay dividends?

No. Tianjin Zhongxin Pharmaceutical Group Corp Ltd does not pay a dividend.

What is Tianjin Zhongxin Pharmaceutical Group Corp Ltd (600329) beta (volatility) score?

Tianjin Zhongxin Pharmaceutical Group Corp Ltd has a beta of 0.519, indicating lower volatility than the overall market.